Interestingly, the combination of XPO1 and tamoxifen blocked the activation of the AKT signalling pathway, induced autophagy, improved the treatment sensitivity to tamoxifen and reshaped the tumour metabolic pathway, which provided a new approach for the future treatment of breast cancer.133, 134. The gene discussed is AKT1; the disease is breast cancer.